Literature DB >> 25862513

Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.

Sandra N Ekdawi1, James M P Stewart2, Michael Dunne1, Shawn Stapleton3, Nicholas Mitsakakis1, Yannan N Dou1, David A Jaffray4, Christine Allen5.   

Abstract

Existing paradigms in nano-based drug delivery are currently being challenged. Assessment of bulk tumor accumulation has been routinely considered an indicative measure of nanomedicine potency. However, it is now recognized that the intratumoral distribution of nanomedicines also impacts their therapeutic effect. At this time, our understanding of the relationship between the bulk (i.e., macro-) tumor accumulation of nanocarriers and their intratumoral (i.e., micro-) distribution remains limited. Liposome-based drug formulations, in particular, suffer from diminished efficacy in vivo as a result of transport-limiting properties, combined with the heterogeneous nature of the tumor microenvironment. In this report, we perform a quantitative image-based assessment of macro- and microdistribution of liposomes. Multi-scalar assessment of liposome distribution was enabled by a stable formulation which co-encapsulates an iodinated contrast agent and a near-infrared fluorescence probe, for computed tomography (CT) and optical microscopy, respectively. Spatio-temporal quantification of tumor uptake in orthotopic xenografts was performed using CT at the bulk tissue level, and within defined sub-volumes of the tumor (i.e., rim, periphery and core). Tumor penetration and relative distribution of liposomes were assessed by fluorescence microscopy of whole tumor sections. Microdistribution analysis of whole tumor images exposed a heterogeneous distribution of both liposomes and tumor vasculature. Highest levels of liposome uptake were achieved and maintained in the well-vascularized tumor rim over the study period, corresponding to a positive correlation between liposome and microvascular density. Tumor penetration of liposomes was found to be time-dependent in all regions of the tumor however independent of location in the tumor. Importantly, a multi-scalar comparison of liposome distribution reveals that macro-accumulation in tissues (e.g., blood, whole tumor) may not reflect micro-accumulation levels present within specific regions of the tumor as a function of time.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computed tomography; Intratumoral distribution; Liposome; Nanomedicine; Optical microscopy; Tumor accumulation

Mesh:

Substances:

Year:  2015        PMID: 25862513     DOI: 10.1016/j.jconrel.2015.04.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  26 in total

Review 1.  Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

Authors:  Emily B Ehlerding; Piotr Grodzinski; Weibo Cai; Christina H Liu
Journal:  ACS Nano       Date:  2018-03-01       Impact factor: 15.881

2.  Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models.

Authors:  Einar Sulheim; Jana Kim; Annemieke van Wamel; Eugene Kim; Sofie Snipstad; Igor Vidic; Ingeborg Hovde Grimstad; Marius Widerøe; Sverre H Torp; Steinar Lundgren; David J Waxman; Catharina de Lange Davies
Journal:  J Control Release       Date:  2018-04-21       Impact factor: 9.776

3.  Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.

Authors:  Ameya R Kirtane; Tanmoy Sadhukha; Hyunjoon Kim; Vidhi Khanna; Brenda Koniar; Jayanth Panyam
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

4.  Multiplex Three-Dimensional Mapping of Macromolecular Drug Distribution in the Tumor Microenvironment.

Authors:  Steve Seung-Young Lee; Vytautas P Bindokas; Stephen J Kron
Journal:  Mol Cancer Ther       Date:  2018-10-15       Impact factor: 6.261

Review 5.  Integrating nanomedicine into clinical radiotherapy regimens.

Authors:  Allison N DuRoss; Megan J Neufeld; Shushan Rana; Charles R Thomas; Conroy Sun
Journal:  Adv Drug Deliv Rev       Date:  2019-07-04       Impact factor: 15.470

6.  Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment.

Authors:  Oliver K Appelbe; Qingbei Zhang; Charles A Pelizzari; Ralph R Weichselbaum; Stephen J Kron
Journal:  Mol Pharm       Date:  2016-09-01       Impact factor: 4.939

Review 7.  Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.

Authors:  Qi Yang; Christina L Parker; Justin D McCallen; Samuel K Lai
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

8.  Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes.

Authors:  J T Sutton; K J Haworth; S K Shanmukhappa; M R Moody; M E Klegerman; J K Griffin; D M Patton; D D McPherson; C K Holland
Journal:  Drug Deliv       Date:  2016-09-30       Impact factor: 6.419

Review 9.  Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.

Authors:  P S Thakur; A M Khan; S Talegaonkar; F J Ahmad; Z Iqbal
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-26       Impact factor: 4.553

Review 10.  Enhancing Tumor Penetration of Nanomedicines.

Authors:  Qingxue Sun; Tarun Ojha; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Biomacromolecules       Date:  2017-03-31       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.